Gardner Lewis Asset Management’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

Gardner Lewis Asset Management’s Portfolio ETTX Stock Details ETTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,249,778	Closed	-$2.75M	–	98
2022 Q2	$2.75M	Buy	+1,249,778	New	+$2.5M	0.55%	52

Gardner Lewis Asset Management's ETTX Position: Q3 2022 in Review

Gardner Lewis Asset Management sold out of Entasis Therapeutics Holdings Inc. (ETTX) in Q3 2022, closing a stake of 1,249,778 shares — an estimated $2.75M sold.

Gardner Lewis Asset Management first reported a position in ETTX in Q2 2022 and held it in 1 quarter. The position peaked at $2.75M in Q2 2022. 0 funds tracked by Wall St. Rank hold ETTX as of Q3 2022.

Gardner Lewis Asset Management reported no remaining Entasis Therapeutics Holdings Inc. position as of Q3 2022 after selling out during the quarter.
Gardner Lewis Asset Management sold 1,249,778 Entasis Therapeutics Holdings Inc. shares in Q3 2022, an estimated $2.75M.
Gardner Lewis Asset Management first reported a position in Entasis Therapeutics Holdings Inc. in Q2 2022 and held it in 1 quarter.
Gardner Lewis Asset Management's Entasis Therapeutics Holdings Inc. position peaked at $2.75M in Q2 2022.
0 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q3 2022.

Based on Gardner Lewis Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.